13D/13G Filings - Schneid Yair

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-09-26
4:45 pm
Sale
2024-09-2313GReShape Lifesciences Inc.
RSLS
Schneid Yair37,407
8.374%
-5,024decrease
(-11.84%)
Filing
History
2024-05-16
10:26 am
Unchanged
2024-04-1613GGalera Therapeutics, Inc.
GRTX
Schneid Yair10,823,610
19.900%
0
(Unchanged)
Filing
History
2024-05-01
5:01 pm
Purchase
2024-04-1913GGalera Therapeutics, Inc.
GRTX
Schneid Yair10,823,610
19.900%
3,712,809increase
(+52.21%)
Filing
History
2024-01-16
6:09 pm
Purchase
2024-01-0513GGalera Therapeutics, Inc.
GRTX
Schneid Yair7,110,801
13.073%
7,110,801increase
(New Position)
Filing
History
2024-01-16
6:07 pm
Purchase
2024-01-0513GReShape Lifesciences Inc.
RSLS
Schneid Yair42,431
10.525%
42,431increase
(New Position)
Filing
History